Evaluation of the suitability of a 5-ALA patch (PD P 506 A, Alacare) in the photodynamic therapy (PDT) of actinic keratosis on the upper extremities - AK 13
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2019
Price : $35 *
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Acronyms AK 13
- Sponsors Photonamic
- 26 Aug 2019 Status changed from recruiting to active, no longer recruiting.
- 21 May 2019 Status changed from not yet recruiting to recruiting.
- 13 Nov 2018 New trial record